These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 18950631)
1. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gao Y; Kristinsson SY; Goldin LR; Björkholm M; Caporaso NE; Landgren O Gastroenterology; 2009 Jan; 136(1):91-8. PubMed ID: 18950631 [TBL] [Abstract][Full Text] [Related]
2. Family history of hematopoietic malignancy and risk of lymphoma. Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371 [TBL] [Abstract][Full Text] [Related]
4. Does celiac disease influence survival in lymphoproliferative malignancy? Ludvigsson JF; Lebwohl B; Rubio-Tapia A; Murray JA; Green PH; Ekbom A; Granath F Eur J Epidemiol; 2013 Jun; 28(6):475-83. PubMed ID: 23463575 [TBL] [Abstract][Full Text] [Related]
5. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Mearin ML; Catassi C; Brousse N; Brand R; Collin P; Fabiani E; Schweizer JJ; Abuzakouk M; Szajewska H; Hallert C; Farré Masip C; Holmes GK; Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):187-94. PubMed ID: 16394801 [TBL] [Abstract][Full Text] [Related]
6. Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma. Charbonneau B; O'Connor HM; Wang AH; Liebow M; Thompson CA; Fredericksen ZS; Macon WR; Slager SL; Call TG; Habermann TM; Cerhan JR J Nutr; 2013 May; 143(5):672-81. PubMed ID: 23486982 [TBL] [Abstract][Full Text] [Related]
7. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886 [TBL] [Abstract][Full Text] [Related]
8. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923 [TBL] [Abstract][Full Text] [Related]
9. Survival patterns among lymphoma patients with a family history of lymphoma. Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984 [TBL] [Abstract][Full Text] [Related]
10. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Wang SS; Slager SL; Brennan P; Holly EA; De Sanjose S; Bernstein L; Boffetta P; Cerhan JR; Maynadie M; Spinelli JJ; Chiu BC; Cocco PL; Mensah F; Zhang Y; Nieters A; Dal Maso L; Bracci PM; Costantini AS; Vineis P; Severson RK; Roman E; Cozen W; Weisenburger D; Davis S; Franceschi S; La Vecchia C; Foretova L; Becker N; Staines A; Vornanen M; Zheng T; Hartge P Blood; 2007 Apr; 109(8):3479-88. PubMed ID: 17185468 [TBL] [Abstract][Full Text] [Related]
11. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Paltiel O; Schmit T; Adler B; Rachmilevitz EA; Polliack A; Cohen A; Haim N; Shachar MB; Epelbaum R; Barchana M; Cohen R; Ben Yehuda D Cancer; 2000 May; 88(10):2357-66. PubMed ID: 10820359 [TBL] [Abstract][Full Text] [Related]
12. The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study. Taborelli M; Montella M; Libra M; Tedeschi R; Crispo A; Grimaldi M; Dal Maso L; Serraino D; Polesel J BMC Cancer; 2017 Jun; 17(1):421. PubMed ID: 28622762 [TBL] [Abstract][Full Text] [Related]
13. Risk of non-Hodgkin lymphoma in celiac disease. Catassi C; Fabiani E; Corrao G; Barbato M; De Renzo A; Carella AM; Gabrielli A; Leoni P; Carroccio A; Baldassarre M; Bertolani P; Caramaschi P; Sozzi M; Guariso G; Volta U; Corazza GR; JAMA; 2002 Mar; 287(11):1413-9. PubMed ID: 11903028 [TBL] [Abstract][Full Text] [Related]
14. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177 [TBL] [Abstract][Full Text] [Related]
15. Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study. Crump C; Sundquist K; Sieh W; Winkleby MA; Sundquist J J Natl Cancer Inst; 2012 Jun; 104(12):923-30. PubMed ID: 22623506 [TBL] [Abstract][Full Text] [Related]
16. Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects. McDuffie HH; Pahwa P; Karunanayake CP; Spinelli JJ; Dosman JA BMC Cancer; 2009 Feb; 9():70. PubMed ID: 19250521 [TBL] [Abstract][Full Text] [Related]
17. Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach. Carroccio A; Iannitto E; Di Prima L; Cirrincione S; Troncone R; Paparo F; Trapani LG; Gucciardi A; Averna MR; Montalto G; Notarbartolo A Dig Dis Sci; 2003 Aug; 48(8):1530-6. PubMed ID: 12924648 [TBL] [Abstract][Full Text] [Related]
18. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034 [TBL] [Abstract][Full Text] [Related]
19. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425 [TBL] [Abstract][Full Text] [Related]
20. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Altieri A; Bermejo JL; Hemminki K Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]